Track the Seelos Therapeutics, INC. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Seelos Therapeutics, INC. has recorded 9 reports. Market capitalisation: €58. The latest transaction was reported on 1 March 2024 (Attribution). Among the most active insiders: Golembiewski Michael Joseph. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.